Pharma reshoring: Amgen invests $900M in Ohio biotech facility
In This Article:
Amgen (AMGN) has announced a $900 million expansion of its Ohio biotech manufacturing facility.
Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to explain the details, noting that this follows a previous $1 billion investment in North Carolina and is part of a broader trend of reshoring pharma manufacturing.
To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
Related Videos
Terms and Privacy Policy